Green micellar solvent-free HPLC and spectrofluorimetric determination of favipiravir as one of COVID-19 antiviral regimens

Current pharmacological treatments for COVID‐19: What's next?

(2020) Cristina Scavone et al.   BRITISH JOURNAL OF PHARMACOLOGY

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

(2020) Qingxian Cai et al.   Engineering

AGREE—Analytical GREEnness Metric Approach and Software

(2020) Francisco Pena-Pereira et al.   ANALYTICAL CHEMISTRY

Solvent‐free mixed micellar mobile phases: An advanced green chemistry approach for reversed‐phase HPLC determination of some antihypertensive drugs

(2020) Adel Ehab Ibrahim et al.   JOURNAL OF SEPARATION SCIENCE

A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19

(2020) Yohei Doi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Validation of HPLC-UV Multi-Residue Method for the Simultaneous Determination of Tetracycline, Oxytetracycline, Spiramycin and Neospiramycin in Raw Milk

(2020) Hanaa Saleh et al.   Food Analytical Methods

Experimental design approach for development of spectrofluorimetric method for determination of favipiravir; a potential therapeutic agent against COVID-19 virus: Application to spiked human plasma

(2020) Safa M. Megahed et al.   SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY

Detection and quantification of Covid-19 antiviral drugs in biological fluids and tissues

(2020) Maria A. Acquavia et al.   TALANTA

Mixed micellar liquid chromatographic method for simultaneous determination of norfloxacin and tinidazole in pharmaceutical tablets

(2019) Amira H. Kamal et al.   MICROCHEMICAL JOURNAL

A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index

(2018) J. Płotka-Wasylka   TALANTA

Analysis of basic drugs by liquid chromatography with environmentally friendly mobile phases in pharmaceutical formulations

(2017) E. Peris-García et al.   MICROCHEMICAL JOURNAL

Favipiravir pharmacokinetics in Ebola-Infected patients of the JIKI trial reveals concentrations lower than targeted

(2017) Thi Huyen Tram Nguyen et al.   PLoS Neglected Tropical Diseases

Favipiravir Pharmacokinetics in Nonhuman Primates and Insights for Future Efficacy Studies of Hemorrhagic Fever Viruses

(2016) Vincent Madelain et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials

(2016) Vincent Madelain et al.   CLINICAL PHARMACOKINETICS

Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever

(2015) Brian B. Gowen et al.   ANTIVIRAL RESEARCH

Micellar Liquid Chromatography from Green Analysis Perspective

(2015) Rania N. El-Shaheny et al.   Open Chemistry

The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices

(2013) Agnieszka Gałuszka et al.   TRAC-TRENDS IN ANALYTICAL CHEMISTRY

Analytical Eco-Scale for assessing the greenness of analytical procedures

(2012) Agnieszka Gałuszka et al.   TRAC-TRENDS IN ANALYTICAL CHEMISTRY

Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells

(2009) D. F. Smee et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin

(2008) Brian B. Gowen et al.   PLoS One